Clover Health Investments Corp. (NASDAQ: CLOV) is -44.89% lower on its value in year-to-date trading and has touched a low of $1.95 and a high of $8.58 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CLOV stock was last observed hovering at around $2.10 in the last trading session, with the day’s loss setting it -0.05% off its average median price target of $3.00 for the next 12 months. It is also 70.71% off the consensus price target high of $7.00 offered by 6 analysts, but current levels are -2.5% lower than the price target low of $2.00 for the same period.
Currently trading at $2.05, the stock is -18.16% and -24.98% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.05 million and changing -2.38% at the moment leaves the stock -28.96% off its SMA200. CLOV registered -73.98% loss for a year compared to 6-month loss of -45.19%.
The stock witnessed a -28.57% gain in the last 1 month and extending the period to 3 months gives it a -12.02%, and is -12.02% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.34% over the week and 5.37% over the month.
Clover Health Investments Corp. (CLOV) has around 680 employees, a market worth around $1.02B and $2.58B in sales. Profit margin for the company is -15.50%. Distance from 52-week low is 5.13% and -76.11% from its 52-week high. The company has generated returns on investments over the last 12 months (-114.70%).
Clover Health Investments Corp. (CLOV) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Clover Health Investments Corp. (CLOV) is a “Hold”. 6 analysts offering their recommendations for the stock have an average rating of 3.00, where 3 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.
Clover Health Investments Corp. is expected to release its quarterly report on 11/07/2022.The EPS is expected to grow by 29.00% this year
Clover Health Investments Corp. (CLOV) Top Institutional Holders
The shares outstanding are 476.06M, and float is at 337.70M with Short Float at 10.63%.
Clover Health Investments Corp. (CLOV) Insider Activity
A total of 5 insider transactions have happened at Clover Health Investments Corp. (CLOV) in the last six months, with sales accounting for 0 and purchases happening 5 times. The most recent transaction is an insider purchase by SHAPIRO LEE, the company’s Director. SEC filings show that SHAPIRO LEE bought 80,000 shares of the company’s common stock on Mar 11 at a price of $3.10 per share for a total of $0.25 million. Following the purchase, the insider now owns 0.11 million shares.
Clover Health Investments Corp. disclosed in a document filed with the SEC on Mar 03 that Clinton Chelsea (Director) bought a total of 100,000 shares of the company’s common stock. The trade occurred on Mar 03 and was made at $2.53 per share for $0.25 million. Following the transaction, the insider now directly holds 100000.0 shares of the CLOV stock.
Still, SEC filings show that on Nov 22, Palihapitiya Chamath (10% Owner) acquired 1,739,130 shares at an average price of $5.75 for $10.0 million. The insider now directly holds 1,739,130 shares of Clover Health Investments Corp. (CLOV).